SASTASUNDR2024-10-012024-12-31 SASTASUNDR2024-10-012024-12-31 SASTASUNDR2024-10-012024-12-31in-bse-fin:OneOtherRevenueFromOperations01Member SASTASUNDR2024-10-012024-12-31in-bse-fin:FourOtherRevenueFromOperations01Member SASTASUNDR2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member SASTASUNDR2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member SASTASUNDR2024-12-31 SASTASUNDR2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue01Member SASTASUNDR2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue02Member SASTASUNDR2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue01Member SASTASUNDR2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue02Member SASTASUNDR2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults01Member SASTASUNDR2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults02Member SASTASUNDR2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults01Member SASTASUNDR2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults02Member SASTASUNDR2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets01Member SASTASUNDR2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets02Member SASTASUNDR2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member SASTASUNDR2024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member SASTASUNDR2024-12-31 SASTASUNDR2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member SASTASUNDR2024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member SASTASUNDR2024-10-012024-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member SASTASUNDR2024-10-012024-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 533259 SASTASUNDR NOTLISTED Sastasundar Ventures Limited Equity 2024-04-01 2025-03-31 2025-02-14 2025-02-07 INR Lakhs Third quarter 2025-02-14 15:30:00 2025-02-14 17:00:00 false Not applicable Multi segment 2024-10-01 2024-12-31 Unaudited Consolidated 1899000.00 0.00 0.00 0.00 11722000.00 0.00 2790822000.00 7341000.00 1121000.00 2812905000.00 -118296000.00 2694609000.00 3547000.00 2675640000.00 -48822000.00 112338000.00 501000.00 14311000.00 0.00 0.00 0.00 0.00 307181000.00 3064696000.00 -370087000.00 -22332000.00 -392419000.00 151983000.00 -144150000.00 7833000.00 -400252000.00 0.00 0.00 0.00 22334000.00 -377918000.00 889000.00 -377029000.00 -269357000.00 -108561000.00 -268692000.00 -108337000.00 318105000.00 10 -8.47 -8.47 0.00 0.00 -8.47 -8.47 0.00 0.00 0.00 1. The above Unaudited Consolidated Financial Results for the quarter and nine month ended December 31, 2024 have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on February 14, 2025. The Limited Review for the quarter and nine month ended December 31, 2024 has been carried out by the Statutory Auditors, as required under Regulation 33 of SEBI (LODR) Regulation, 2015. 2. As on December 31, 2024, Sastasundar Ventures Limited (“the Group) being holding company comprises of three Wholly Owned Subsidiary , one Subsidiary and ten Step-down Subsidiary (including LLPs) and one Associate Company ( Refer Note 8). 4. Exceptional items represent the gain on following transaction/ event: a) During the Financial Year 2022-23, subsidiaries of the Company had expensed Rs. 796.45 Lakhs under the heading “Exceptional Item”. Sastasundar Healthbuddy Limited, subsidiary of the Company has now recovered Rs. 100.00 Lakhs against the aforesaid amount which has been booked as income in the consolidated financial result for the nine month ended December 31, 2024 under the heading “exceptional item” b) The subsidiary of the company, Sastasundar Healthbuddy Limited, has liquidated its investment held in the form of 0.01% Non-Cumulative Compulsory Convertible Preference share and Equity shares in Flipkart Health Limited on 29th October 2024 as per Share Purchase Agreement dated 28th October 2024 and received a consideration of Rs 9,717.29 Lakhs in aggregate. This has resultant loss of Rs 19,118.54 Lakhs has been booked as exceptional items in the consolidated financial result for the nine month ended December 31, 2024 including Rs. 223.32 Lakhs of current quarter December, 2024. c) The management of one of the step down subsidiary, Genu Path Labs Limited, has evaluated its business operation and the management is of the opinion that the Property, Plant & Equipment as held by it needs to be impaired. Accordingly the company has accounted for an impairment loss of Rs 72.37 Lakhs and disclosed the same as Exceptional item in the consolidated financial result for the nine month ended December 31, 2024. 5. Happymate Foods Limited, step down subsidiary of the company had started its operation in fast moving consumer goods in 2018 with an aim to reach the consumer with a premium brand. The company has taken various steps since then to build distribution channel & offline stores, which did not turn out as expected and losses has been incurred. Presently the company is into discussion with business partner on further plans of restructuring its business. 8. The subsidiary of the company, Sastasundar Healthbuddy Limited, has liquidated its investment in Associate Company i.e. Flipkart Health Limited on 29th October, 2024. Share of Profit/ (Loss) from an associate company till 29th October, 2024 has been consolidated in the above results. 9. The figures for the quarter ended December 31, 2024 are the balancing figures between unaudited figures for the nine month ended December 31, 2024 and unaudited figures for the Half Yearly ended September 30, 2024. 10. Previous Period/ Year figures have been re-grouped / re-classified wherever necessary. Multi segment 2024-04-01 2024-12-31 Unaudited Consolidated 5712000.00 3038000.00 0.00 0.00 177127000.00 0.00 8037389000.00 24421000.00 3454000.00 8251141000.00 382131000.00 8633272000.00 14315000.00 7471209000.00 35622000.00 334805000.00 2042000.00 44920000.00 0.00 0.00 0.00 0.00 703532000.00 8606445000.00 26827000.00 -1909091000.00 -1882264000.00 155248000.00 -634401000.00 -479153000.00 -1403111000.00 0.00 0.00 0.00 -108040000.00 -1511151000.00 2724000.00 -1508427000.00 -1048391000.00 -462760000.00 -1046361000.00 -462066000.00 318105000.00 10 -32.96 -32.96 0.00 0.00 -32.96 -32.96 0.00 0.00 0.00 Other financial income 1121000.00 Other financial income 3454000.00 Other Expenses 307181000.00 Other Expenses 703532000.00 0.00 0.00 0.00 0.00 Financial Services 14734000.00 Healthcare Network 2798171000.00 Financial Services 189323000.00 Healthcare Network 8061818000.00 2812905000.00 8251141000.00 2812905000.00 8251141000.00 Financial Services 9641000.00 Healthcare Network -276516000.00 Financial Services 169533000.00 Healthcare Network -2403703000.00 -266875000.00 -2234170000.00 501000.00 2042000.00 125043000.00 -353948000.00 -392419000.00 -1882264000.00 Financial Services 820910000.00 Healthcare Network 8120973000.00 8941883000.00 645417000.00 9587300000.00 Financial Services 55762000.00 Healthcare Network 975631000.00 1031393000.00 12505000.00 1043898000.00 3. The Group has identified the following segments: a) Financial Services - consists mainly of financing of loans and investment in shares and securities, financial consultancy, professional fees, wealth management, financial planning, distribution and related services. b) Healthcare Network - includes activities for pathology, food processing and marketing of healthcare and OTC products through e-commerce portal and diagnostic services which consist of pathological / radiological investigations. Remeasurement gain/ (loss) on defined benefit plans (net of tax) 908000.00 Remeasurement gain/ (loss) on defined benefit plans (net of tax) 2782000.00 908000.00 2782000.00 19000.00 58000.00 0.00 0.00 889000.00 2724000.00